Database Update: Pharmaceutical Drug Import to Russia (October 2017)
Between January and October 2017, Russian imported 498.3 bln RUB worth of pharmaceutical drugs (free circulation prices, VAT included), which is in monetary terms 4.2% higher than that of the same period of 2016. Ready-made drugs account for most imports (420 bln RUB), with an 8.9% increase in monetary terms. The in-bulk import has fallen by as much as 15.4%, with 78.2 bln RUB.
In October 2017, the long-term growth rates of import of ready-made drugs were not higher than 5%, while it had been around 13% by August-September. Even before the high season, the market situation does not seem very promising, therefore the players are being careful not to overstock. The import of in-bulk products has increased by 17% against the same period of 2016, which is not that impressive though, considering the devastating 39% fall in September.
In physical terms, the numbers are pretty much the same. Between January and October 20017, Russia imported 1.65 mln worth of ready-made drugs, or around 29.7 bln minimum dosage units (MDU), with a 5.9% rise and a 2.5% fall, respectively. Even though the in-bulk import has risen by 4.3% if calculated in MDU, it does not change the situation drastically, with a 1.8% decrease.
Read more about pharmaceutical drug import to Russia (September performance) here: http://rncph.com/news/13_10_2017
Dynamics of import of pharmaceuticals, including homeopathic and seawater drugs, to Russia, free circulation prices including customs clearance and VAT, RUB (January 2016 – October 2017)